PCSK9 inhibitor and atorvastatin reduce cardiac impairment in ovariectomized prediabetic rats via improved mitochondrial function and Ca<sup>2+</sup> regulation
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd Post-menopausal women have a higher risk of developing cardiometabolic dysfunction. Atorvastatin attenuates dyslipidaemia and cardiac dysfunction...
Saved in:
Main Authors: | Patchareeya Amput, Siripong Palee, Busarin Arunsak, Wasana Pratchayasakul, Chanisa Thonusin, Sasiwan Kerdphoo, Thidarat Jaiwongkam, Siriporn C. Chattipakorn, Nipon Chattipakorn |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087555266&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70194 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese rats
by: Busarin Arunsak, et al.
Published: (2020) -
PCSK9 inhibitor effectively attenuates cardiometabolic impairment in obese-insulin resistant rats
by: Patchareeya Amput, et al.
Published: (2020) -
The comparative effects of high dose atorvastatin and proprotein convertase subtilisin/kexin type 9 inhibitor on the mitochondria of oxidative muscle fibers in obese-insulin resistant female rats
by: Chanisa Thonusin, et al.
Published: (2019) -
Exercise with calorie restriction improves cardiac function via attenuating mitochondrial dysfunction in ovariectomized prediabetic rats
by: Siripong Palee, et al.
Published: (2020) -
A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats
by: Chanisa Thonusin, et al.
Published: (2020)